JP2010526859A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526859A5
JP2010526859A5 JP2010507982A JP2010507982A JP2010526859A5 JP 2010526859 A5 JP2010526859 A5 JP 2010526859A5 JP 2010507982 A JP2010507982 A JP 2010507982A JP 2010507982 A JP2010507982 A JP 2010507982A JP 2010526859 A5 JP2010526859 A5 JP 2010526859A5
Authority
JP
Japan
Prior art keywords
cmbp
gly
cys
imaging agent
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010507982A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526859A (ja
Filing date
Publication date
Priority claimed from GB0709441A external-priority patent/GB0709441D0/en
Priority claimed from GB0715682A external-priority patent/GB0715682D0/en
Application filed filed Critical
Priority claimed from PCT/GB2008/001696 external-priority patent/WO2008139207A2/en
Publication of JP2010526859A publication Critical patent/JP2010526859A/ja
Publication of JP2010526859A5 publication Critical patent/JP2010526859A5/ja
Pending legal-status Critical Current

Links

JP2010507982A 2007-05-16 2008-05-16 ペプチドイメージング剤 Pending JP2010526859A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0709441A GB0709441D0 (en) 2007-05-16 2007-05-16 Peptide imaging agents
GB0715682A GB0715682D0 (en) 2007-08-13 2007-08-13 Peptide imaging agents
PCT/GB2008/001696 WO2008139207A2 (en) 2007-05-16 2008-05-16 Labelled hgf binding peptides for imaging

Publications (2)

Publication Number Publication Date
JP2010526859A JP2010526859A (ja) 2010-08-05
JP2010526859A5 true JP2010526859A5 (enExample) 2012-06-21

Family

ID=39743846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507982A Pending JP2010526859A (ja) 2007-05-16 2008-05-16 ペプチドイメージング剤

Country Status (17)

Country Link
US (1) US8529874B2 (enExample)
EP (1) EP2146749B1 (enExample)
JP (1) JP2010526859A (enExample)
KR (2) KR101578225B1 (enExample)
CN (1) CN101848734B (enExample)
AT (1) ATE551073T1 (enExample)
AU (1) AU2008249821B2 (enExample)
BR (1) BRPI0811210B1 (enExample)
CA (1) CA2685553C (enExample)
ES (1) ES2385066T3 (enExample)
IL (1) IL201778A0 (enExample)
MX (1) MX2009012386A (enExample)
NZ (1) NZ581160A (enExample)
PL (1) PL2146749T3 (enExample)
RU (2) RU2475266C2 (enExample)
WO (1) WO2008139207A2 (enExample)
ZA (1) ZA200908016B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811588A2 (pt) * 2007-05-16 2014-10-21 Ge Healthcare As Agente de formação de imagem, composição farmacêutica, kit para a preparação da mesma, conjugado, corante de cianina, e, métodos de formação de imagem óptica in vivo do corpo de um mamífero e de detecção, avaliação do estágio, diagnóstico, monitoração da progressão da doença ou monitoração do tratamento de um estado de doença do corpo de um mamífero
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0918321D0 (en) 2009-10-20 2009-12-02 Ge Healthcare As Cyclic peptide synthesis
GB201010878D0 (en) 2010-06-29 2010-08-11 Ge Healthcare As Dye compositiion and dye syntheses
WO2012001063A1 (en) * 2010-06-29 2012-01-05 Ge Healthcare As Dye compositions and dye syntheses
GB201013808D0 (en) 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
WO2012048063A2 (en) * 2010-10-06 2012-04-12 Emd Millipore Corporation Cyanine compounds, conjugates and method of use
CA2828810A1 (en) 2011-03-01 2012-09-07 Ge Healthcare Limited Radiolabelled octreotate analogues as pet tracers
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
DE102011118029A1 (de) * 2011-06-20 2012-12-20 Universität Leipzig Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung
GB201116733D0 (en) 2011-09-28 2011-11-09 Ge Healthcare As Peptide margin imaging agents
GB201116862D0 (en) 2011-09-30 2011-11-09 Ge Healthcare As Infusion imaging method
GB201121914D0 (en) * 2011-12-20 2012-02-01 Ge Healthcare Ltd Method for patient selection
US10046068B2 (en) * 2013-03-15 2018-08-14 Arizona Board Of Regents On Behalf Of Arizona State University Saccharide conjugates
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
CN105111773B (zh) * 2015-08-19 2017-06-27 大连理工大学 一类氨基菁类荧光染料及其制备方法和应用
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
CN112129736B (zh) * 2020-09-22 2022-08-02 四川大学华西医院 粘蛋白和循环肿瘤细胞的均相可视化/荧光poct检测方法
EP4352167A1 (en) * 2021-06-07 2024-04-17 SurgVision GmbH Stable liquid phantom for near-infrared fluorescence verification
TW202404643A (zh) 2022-04-20 2024-02-01 大陸商同宜醫藥（蘇州）有限公司 化合物及用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258776A1 (en) * 2002-05-10 2010-12-08 Carnegie Mellon University Fluorescent cyanine dyes containing functional groups
GB0223249D0 (en) * 2002-10-08 2002-11-13 Amersham Plc Improved imaging agents
EP1594551A2 (en) * 2003-02-19 2005-11-16 Sicel Technologies, Inc. In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes
PT2949658T (pt) * 2003-03-03 2018-10-18 Bracco Suisse Sa Péptidos que ligam especificamente o recetor de hgf (cmet) e utilizações dos mesmos
NO20034350D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av kolorektal kreft
US7750163B2 (en) * 2003-10-31 2010-07-06 GE Healthcare U.K. Limited Cyanine dye labelling reagents
US7785566B2 (en) 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
NO20035682D0 (no) 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av ösofagkreft og Barretts ösofag
WO2006073314A1 (en) * 2005-01-06 2006-07-13 Ge Healthcare As Optical imaging
US8053415B2 (en) * 2005-01-21 2011-11-08 Washington University In St. Louis Compounds having RD targeting motifs
GB0502277D0 (en) 2005-02-04 2005-03-09 Amersham Plc Novel imaging agents
EP1877428B1 (en) * 2005-04-22 2011-03-16 University of Washington Cyanine- chlorotoxin conjugate and method for intra-operative visualization of cancer
NO20053354D0 (no) 2005-07-11 2005-07-11 Amersham Health As Optical imaging contrast agent.

Similar Documents

Publication Publication Date Title
JP2010526859A5 (enExample)
JP7664158B2 (ja) トランスフェリン受容体標的ペプチド
AU2022202280B2 (en) Controlled-release CNP agonists with low initial NPR-B activity
AU2022221482B2 (en) Controlled-release CNP agonists with low NPR-C binding
US8431111B2 (en) Peptide imaging agents
EP2146749B1 (en) Labelled hgf binding peptides for imaging
AU2017205688C1 (en) Cnp prodrugs with carrier attachment at the ring moiety
AU2017205273C1 (en) Controlled-release CNP agonists with reduced side-effects
AU2019246196B2 (en) Formulation and method of preparation
IL293979B1 (en) Controlled-release cnp agonists with increased nep stability
JP2023541798A (ja) Ｃｒｆ２受容体アゴニスト及び治療におけるその使用
TWI820657B (zh) 針對vegf之d-肽化合物
KR20130024963A (ko) 개선된 ｎ4 킬레이트제 결합체
JP5604305B2 (ja) 線維症の非侵襲性の特異的イメージングのための、ポリペプチド、環状ポリペプチドおよびそれを含む医薬
RU2802481C2 (ru) Состав для оптической визуализации, способ его получения и применение
HK40047564B (en) Formulation and method of preparation
HK1148476A (en) Labelled hgf binding peptides for imaging